Since the initial sequencing of the human genome, many projects are underway to understand the effects of genetic variation between individuals. Predicting and understanding the downstream effects of genetic variation using computational methods are becoming increasingly important for single nucleotide polymorphism (SNP) selection in genetics studies and understanding the molecular basis of disease. According to the NIH, there are now more than four million validated SNPs in the human genome. The volume of known genetic variations lends itself well to an informatics approach. Bioinformaticians have become very good at functional inference methods derived from functional and structural genomics. This review will present a broad overview of the tools and resources available to collect and understand functional variation from the perspective of structure, expression, evolution and phenotype. Additionally, public resources available for SNP identification and characterisation are summarised.
INTRODUCTION
Single nucleotide polymorphisms (SNPs; Table 1 provides a glossary of terms) are the most common form of genetic variation in humans comprising nearly 1/1,000th of the average human genome. 1 Traditionally, SNPs are assumed biallelic, ie only two of the four common nucleotides are found in that position, having their least common nucleotide found in greater than 1 per cent of the population. The distribution and function of SNPs are important areas of current research. Reviews are available for understanding how SNPs affect protein structure, the use of SNPs in genetics studies and identifying functional variants in candidate genes. 2À5 This review covers bioinformatics efforts to predict variation that is likely to have a functional effect (and possibly a phenotypic effect) and to classify the downstream molecular effects of those variants.
Research suggests that most SNPs fall in the 95 per cent non-coding region of the genome. 6 Of the SNPs that are near or in a gene, their effect on function is difficult to determine. SNPs can alter the function of DNA, RNA and proteins, and are generally classed by genomic location ( Table 2) . Non-synonymous SNPs alter the amino acid sequence of the protein product through either amino acid substitution or the introduction of a nonsense/truncation mutation. A variant may also affect the expression or translation of a gene product, either by interrupting a regulatory region or by interfering with normal splicing and mRNA function. This can include SNPs in regulatory regions, synonymous SNPs and intronic SNPs. The molecular effects of variation are now becoming better understood in many cases, and specific examples are discussed in detail later in this paper.
The two types of variation that are usually studied from a functional perspective are polymorphisms with no known phenotype, and phenotypically annotated or disease-associated variation. Polymorphisms without a known phenotype are usually discovered by SNP screening or genomic analysis, while the phenotypically annotated SNPs are often discovered from association studies. Because human mutations are often inferred to be disease-associated through genetics association studies, these mutations may not be causative; they may only be in linkage with the actual causative allele.
Today, the primary database of polymorphisms is dbSNP, 7 which currently contains more than 5,000,000 validated human SNPs. Disease-associated polymorphisms are available from databases such as OMIM, 8 Swiss-Prot, 9 the Human Gene Mutation Database (HGMD) 10 and HGVBase. 11 Together, these databases represent more than 40,000 non-synonymous, synonymous and non-coding polymorphisms.
The first efforts to understand the patterns of sequence variation in the coding regions of genes were studied on two different sets of genes by Cargill et al. 12 and Halushka et al. 13 Cargill et al. characterised variations in 106 genes that were hand selected for their potential relevance to human disease. The authors estimated between 36 and 54 per cent of the non-synonymous mutations were non-conservative, based on the BLOSUM62 matrix. Lau and Chasman have provided further analysis of these data sets.
14 Functional bioinformatics approaches have been applied to the analysis of disease-associated mutations, as well. Several recent reports have focused very precisely on where diseased alleles are occurring on protein structures and what the properties of those mutations are. It has been shown that these mutation positions are conserved evolutionarily, [15] [16] [17] [18] [19] and that they are relevant to protein structure.
18-21 One of the difficulties in analysing diseaseassociated mutations is that it is very difficult to obtain a set of neutral alleles for comparison. Most approaches to collecting neutral mutations contain some amount of false positives. Some have compared against nsSNPs, while others have used accepted mutations in other species. Terp et al. identified structurally relevant features common in diseaseassociated mutations from the HGMD. 22 Further analysis of the biophysical and evolutionary distributions of diseaseassociated mutations was provided by In a region of the genome that is transcribed Haplotype
The organisation of variation across a chromosome Missense mutation A variant that alters a codon to substitute one amino acid for another Nonsense mutation A mutation that introduces a stop codon Rare variant A variation where the least common allele occurs less than 1 per cent in the population SNP (single nucleotide polymorphism)
An inherited single nucleotide substitution between individuals of a species. Commonly defined as having the least frequent allele occur at a rate greater than 1 per cent in a population. The most common form of human variation Ferrer-Costa et al. 23 Stitziel et al. further analysed the locations of nonsynonymous disease-associated polymorphisms by classifying the mutational data into structural classes. 24 Evolutionary conservation and amino acid identities of mutations have been studied in detail. Mooney et al. showed that, in general, disease-associated mutations tend to occur in positions that are conserved. 25, 26 Vitkup et al. examined the frequencies of mutations associated with disease in detail. 27 They found that the prevalence of observed disease-associated mutations correlates strongly with the mutability of the observed genetic code. Together, these reports and the papers discussed in the previous section give a good understanding of the properties of disease-associated mutations. Their positions are conserved evolutionarily and the nature of the mutations are far more likely to be non-conserved than unannotated polymorphisms.
Variation does not occur randomly across genetic sequences and often occurs in hotspots. 28 It is likely that selection has played a role in the evolution of human genetic variation. 29, 30 With this in mind, the following sections summarise the methods and resources available to predict and characterise the function of nonsynonymous, synonymous and noncoding polymorphisms using bioinformatics methods.
WEB RESOURCES AND SOFTWARE TOOLS FOR SNP CHARACTERISATION
Many resources now annotate variation data with functional information. This section identifies interesting and novel resources for SNP annotation and analysis. The simplest approaches classify variants based on their relationship to genes. Information about whether variants occur near a gene, in a coding region, in an exon, in an intron or up-or downstream of the gene is relatively direct using several genome resources. The NCBI databases, such as dbSNP and OMIM, 31 and Ensembl 32 provide visualisation access and some annotations related to function, based on experiment. Furthermore, with the sequencing of several mammalian genomes, comparative sequence analysis is now possible, even for variation outside of exon boundaries. Many locus or disease-specific databases are beginning to integrate functional information, such as protein structure, into their annotation sets. The Human Genome Variation Society maintains a comprehensive list of locus-specific databases, which often contain high-quality annotations on variation in specific genes or diseases. 33 An excellent resource for visualisation of SNP locations and other genome annotations is GoldenPath, the UCSC Genome Browser and genome assembly. 34 Here, an incredible array of annotations has been assembled. Furthermore, the database is completely in the public domain, and trivially importable into a relational database, such as MySQL. 35 The other primary genome resource is Ensembl. 36 Within Ensembl, users can visualise variation in and around genes, and their data annotations are of high quality and embedded into an elegant interface. Another powerful resource for SNP analysis is SNPper. 37, 38 SNPper was created in the Kohane Lab at Harvard University for the analysis of SNPs. SNPper focuses on SNP selection for genetic studies, and is a valuable tool for the geneticist. The National Cancer Institute has developed several SNP analysis tools as part of its Cancer Genome Anatomy Project's Genetic Annotation Initiative (CGAP-GAI). 39, 40 Figure 1 displays SNPs in the BRCA1 gene using SNPper, Ensembl and UCSC's GoldenPath Genome Browser. Table 3 summarises SNP databases and tools for SNP analysis.
BIOINFORMATICS APPROACHES TO PREDICTING FUNCTIONAL NON-SYNONYMOUS SNPS
Much effort has been invested in predicting the function of nonAnnotated genome databases are excellent resources for SNP annotations synonymous mutations, based on evidence that regulatory and coding SNPs are most likely to affect disease 42-44 and the wide availability of functional data on proteins. An important question is understanding whether a particular mutation will be tolerated. 45 There are several ways an nsSNP can affect gene product function. The most probable effect is a partial or complete loss of function of the mutated gene product. A less likely possibility is a gain of function 46 or the activation (by loss of GTPase activity) of the RAS oncogene. 47 Researchers have taken several approaches to predict the function of nsSNPs. Almost all methods use categories, or discrete or continuous valued features to predict a deleterious mutation. These features range from sequence-based properties, physical properties of the wild-type and mutant amino acids, protein structural properties and evolutionary properties derived from a phylogeny or sequence alignment. To classify whether a mutation will be tolerated, a training set is usually constructed of mutations known to be deleterious. For example, these training sets can be derived from saturation mutagenesis experiments where mutation severity is determined in activity assays, 16, 18, 21, 48, 49 multiple sequence alignments where tolerance to mutation is derived from evolutionary analyses of sequence positions, 19 or known deleterious human mutations.
18
The earliest studies analysed mutations using sequence properties based on how conservative a mutation was, using a BLOSUM62 matrix.
12 BLOSUM62 does not take into account the sequence or structural context of the mutation, so further efforts were employed to include position-specific conservation estimates and protein structural information. Ng and Henikoff continued this body of research by developing a position specific estimation of non-conservative mutations with their method, Sorting Intolerant From Tolerant (SIFT), 49, 50 to find that 25 per cent of nsSNPs in dbSNP are likely to affect protein function. 17 SIFT is based on a position-specific scoring matrix (PSSM), and estimates positions that will be unfavourable to mutation, based on tolerated mutations in homologues. SIFT has recently been applied to SNPs in both DNA repair genes and separately to BRCA1. 51, 52 An early study to classify and survey non-synonymous SNPs that included protein structural features was that of Sunyaev et al. 20 The authors compared disease-associated mutations in orthologous genes and human cSNPs. To assess local functionality for a given position, both protein structural information and evolutionary information were taken into account. Protein structural parameters such as solvent In order to assess different features for prediction of intolerant mutations, Saunders and Baker 18 followed the analysis of Sunyaev et al. and Chasman and Adams with a machine learning perspective on the different proposed features. They applied decision trees and a linear logistic regression to find that a protein structure-derived solvent accessibility term (Câ density) and an evolutionary term derived from a PSSM matrix (SIFT) were the most accurate terms for prediction. They carefully selected a human allele training set along with saturation mutagenesis data sets from lac repressor, HIV-1 protease and T4 lysozyme. The human allele training set was carefully selected to contain known deleterious and neutral alleles, as opposed to alleles that had simply been associated a phenotype. They found that decision trees had an overall classification error of 29.6 per cent on the human alleles and 22.9 per cent on the in vitro mutations. They also found that in both human alleles and in vitro cases, the SIFT and Câ density terms classified the best, and that the normalised B-factor and Sunyaevderived structural rules did not improve classification accuracy when incorporated with the former terms in a combined analysis.
Adding to the feature comparison performed by Saunders and Baker, Krishnan and Westhead 21 compared different approaches to classification. They rigorously compared decision trees to support vector machines (SVMs) and applied these methods to the same in vitro mutagenesis data sets as well as to SNPs in the nematode worm species Caenorhabditis elegans. One of their findings showed that introducing structural features reduced their error rate. The features that reduced the error rate include mass and hydrophobicity differences, buried charges, solvent accessibility and secondary structure. In another application of machine learning methods, Saturation mutagenesis experiments are reasonable datasets for training machine learning methods Cai et al. applied a Bayesian method for predicting disease-associated SNPs and obtained relatively low false positive error rates, in exchange for a relatively high false negative rate. 48 In general, prediction methods must balance sensitivity and specificity, where low false positive error rates (high specificity) can only be achieved with low sensitivity.
More recently, at the 'Inferring SNP Function' session at the Pacific Symposium of Biocomputing (PSB), Karchin et al. continued these efforts to identify the most informative features for predicting deleterious mutations. 54 Using the saturation mutagenesis experiments discussed above, they ranked 32 features using mutual information and found that structural features, such as solvent accessibility of the wild type and mutant as well as an evolutionary term, derived from superfamily multiple alignments.
Currently the state-of-the-art classification tools are based on SVMs or decision trees and the best features for classification are based on structural and evolutionary properties. Structurally, solvent accessibility has consistently been shown to be important in determining whether a mutation will be tolerated.
16,18,19,55 Evolutionarily, nontolerated mutations inferred using a PSSM matrix are generally better than using positional conservation approaches.
Several web resources are available for functional annotation of variation, two excellent resources are PolyPhen 55 and SIFT. 50 For a summary, see Table 4 . PolyPhen 55 uses a wide variety of features that are sequence-, evolutionary-and structurally based to predict whether a non-synonymous mutation is likely to affect protein function, and performs optimally if structural information is available. PolyPhen has been applied to all mutations in HGVBase, and a server is provided for the annotation of new mutations. Currently, more than 11,000 non-synonymous mutations are annotated. SIFT is available online for predicting intolerant mutations using position-specific information derived from sequence alignments, and requires only sequence and homologue information. 50 SNPeffect at EMBL annotates SNPs with three categories of functional and chemical properties, protein structure and dynamics, functional sites and cellular processing. 56 SNP3D is another resource for inferring the function of SNPs and incorporates structure, alternative splicing, systems biology and evolutionary information for annotation. 57 Additionally, data on the Swiss-Prot website link to homology models of mutations when available.
Generally, the quality of the method will depend on the amount of input data available to the researcher. If only a sequence is available without known homologues or known structure, the method will not perform as well as if these were available. If only sequence and homologue data are available, SIFT will likely give the best performance. If structure data are available, the PolyPhen method will add to an analysis by SIFT because of its use of that data. For any SIFT and PolyPhen are commonly used resources for classifying uncharacterized nonsynonymous SNPs (Figure 2) . Similarly, PicSNP 59 is a resource that has annotated more than 1.1 million SNPs and classified them into structural and functional groups. Additionally, they also associate mutations to Gene Ontology categories.
BIOINFORMATICS APPROACHES TO PREDICTING FUNCTIONAL SYNONYMOUS VARIATION
Synonymous variation has been shown to be functional as well. In particular, exonic splicing enhancers (ESEs) are short sequences that occur in exons, and they encourage exon recognition by the cell's splicing machine. 60 When mutated, ESEs can affect mRNA splicing and causing exon skipping. 60 Majewski and Ott 61 found that SNPs occur less often near intron-exon boundaries and the frequency of SNPs in both introns and exons increases as the distance from the boundary increases. Indeed, ESEs have relevance to human disease. Diseaseassociated variation that disrupts ESEs were found in the breast cancer-associated genes BRCA1 62,63 and BRCA2. 64 Furthermore, it has been shown that mutations that affect mRNA splicing are the most common type of mutations in neurofibromatosis type 1. 65 An original approach to the analysis of variation that disrupts ESEs was recently reported by Fairbrother et al., where the authors aligned SNPs that are in predicted ESE sites and showed, by comparison to the chimpanzee genome, that these SNPs are under selective pressure. In fact nearly 20 per cent of the polymorphisms have been selected out, and that this is most notable near splicing sites. 66 
BIOINFORMATICS APPROACHES TO PREDICTING FUNCTIONAL NON-CODING VARIATION
Non-coding variation has not received the attention that non-synonymous SNPs and disease-associated mutations have. This is due to difficulties in collecting functional variation information, not to lack of importance. Understanding how variation affects gene expression has been called one of the key challenges in human genetics. 67 The challenge arises from the difficulty in separating regulatory variation (cis-acting factors) from the cellular environment and variation on other chromosomes (trans-acting factors) and the environment. 68 A recent review succinctly summarises the efforts to understand this challenging problem. 69 A key problem for bioinformatics is developing methods to predict variation that is likely to affect expression levels. Mapping variation to known regulatory sites will not complete the entire story, however, because it is not sufficient to know whether a variant is present; it will be necessary to know whether a variant affects, or disrupts, a function, and therefore expression.
Although this area is difficult to study, there are a few studies that have attempted to examine the relationship between gene expression and variation. Most of the projects that aim to identify the prevalence of variation that alters gene expression at the genomic level have done so by coupling computational methods with experimental analysis of gene expression levels using microarrays.
Cowles et al. addressed the problem of removing trans-acting factors by focusing their studies on the expression levels in an F 1 hybrid mouse derived from two inbred mouse strains. This allowed them to remove trans regulation from the results. 68 They studied 69 genes in total and found that 6 per cent (with large error) of those genes had variants that affect detectable gene expression levels. Pastinen et al. examined 129 genes to identify 23 genes that had allele-dependent expression levels. 70 Additionally, Wittkopp et al. compared differences in gene expression between closely related Drosophila species and found that most of the genes with significant expression level differences had cis-regulatory differences. 71 They also found that cis-regulatory differences were more common than trans-regulatory differences.
Hoogendoorn et al. have screened different promoter variants to identify haplotypes that are likely to affect gene expression. 72, 73 Their experiments found that a third of the variants can alter expression levels by more than 50 per cent. Later, Buckland et al. tested the ability of 20 variant promoters on chromosome 21 alter gene expression and found that approximately 18 per cent of the variants altered expression levels by 1.5-fold or more. 74 Very little bioinformatics research has been performed to build predictors of variation that is likely to affect gene expression levels. Currently, identifying whether the position is conserved in model organisms and whether the polymorphism sits in a known regulatory motif remain the only computational way of roughly estimating whether a variant will affect expression levels. For example, Consite is a method that predicts transcription factor binding sites. 75, 76 Surely when well-annotated databases begin to take form, regulatory relevant polymorphism classification will become possible. PupaSNP Finder 77,78 is a tool for identifying SNPs that could have an effect on transcription. Using Ensembl, the authors map SNPs in dbSNP to transcription factor binding sites, intron/ exon border consensus sequences, ESE sequences and variations that are nonsynonymous. Another resource is rSNP_Guide, 79, 80 which contains annotations of SNPs based on potential effects to regulation.
PROGRAMMING TOOLS FOR SNP ANALYSIS
For bioinformatics researchers developing applications or web resources, the BioPerl project 81 has created an open source set of tools for the analysis of biological data. Using this powerful toolset, scientists can quickly analyse local and remote data from dbSNP, Ensembl and other resources. BioPerl is well supported and includes many tools for annotation, visualisation and analysis of genetic variation. Several tutorials are available for learning the intricate details of Perl and BioPerl. 82 Another tool is libsequence, 83 a C++ library containing tools for SNP analysis. Using similar tools, two groups have described the development of a SNP annotation and selection pipeline. 84, 85 
THE FUTURE
The importance and quantity of SNP data now available provide many avenues for future research. First, prediction and classification of non-synonymous mutations using protein structure-based tools need to be improved. Reduction of A challenge for the future is prediction of cis-acting variation that affects gene expression false positive rates is required. Structurebased tools utilising ab initio and comparatively modelled structures will probably be required. For synonymous mutations and non-coding mutations, the spectrum of potential functional disruptions needs to be described. Additionally, for all prediction methods, better training sets are required. These sets need to be rich in both affected and neutral alleles. 17, 18 Finally, controlled vocabularies for describing the range of mutation affects could be valuable for building classification methods. Currently, molecular and physiological phenotypic information is often poorly annotated in either human-readable annotations and the subtleties of specific phenotypes are often unclear. There is no central database for phenotypically annotated mutations, and researchers must search many scattered resources to be thorough. There are also few, if any, resources that give information on complex or multifactorial disease where a condition may be caused by more than a single SNP.
The future for this area of research is bright. It is clear from the initial research efforts that bioinformatics methods that predict molecular effects of mutation will continue to improve. A word of caution must be added, however, that bioinformatic scientists building these methods will have the most success if they choose their learning tools carefully and their training sets to best represent the spectrum of predictions they will be making. Early analysis of many SNPs in important genes. Also the subject of many bioinformatics analysis publications.
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